175 related articles for article (PubMed ID: 33594307)
1. PLG inhibits Hippo signaling pathway through SRC in the hepatitis B virus-induced hepatocellular-carcinoma progression.
Hu ZG; Chen YB; Huang M; Tu JB; Tu SJ; Pan YJ; Chen XL; He SQ
Am J Transl Res; 2021; 13(2):515-531. PubMed ID: 33594307
[TBL] [Abstract][Full Text] [Related]
2. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells
Deng W; Chen F; Zhou Z; Huang Y; Lin J; Zhang F; Xiao G; Liu C; Liu C; Xu L
Front Mol Biosci; 2021; 8():745990. PubMed ID: 34805271
[No Abstract] [Full Text] [Related]
7. RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma.
Zhuo H; Wu C; Tang J; Zhang F; Xu Z; Sun D; Teng Y; Tan Z
J Clin Transl Hepatol; 2023 Apr; 11(2):323-333. PubMed ID: 36643034
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma.
Wu Y; Zhang J; Zhang H; Zhai Y
Oncol Lett; 2016 Sep; 12(3):1971-1974. PubMed ID: 27602122
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
10. ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis.
Si T; Ning X; Chen H; Hu Z; Dun L; Zheng N; Huang P; Yang L; Yi P
J Gastrointest Oncol; 2021 Dec; 12(6):3079-3092. PubMed ID: 35070431
[TBL] [Abstract][Full Text] [Related]
11. Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Zeng XC; Zhang L; Liao WJ; Ao L; Lin ZM; Kang W; Chen WN; Lin X
Front Genet; 2020; 11():555537. PubMed ID: 33193629
[TBL] [Abstract][Full Text] [Related]
12. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
13. Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis.
Kunanopparat A; Kimkong I; Palaga T; Tangkijvanich P; Sirichindakul B; Hirankarn N
World J Gastroenterol; 2016 Oct; 22(37):8361-8374. PubMed ID: 27729742
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway.
Tu W; Yang Y; Song Y; Zhu W
J Biochem; 2019 May; 165(5):423-431. PubMed ID: 30690477
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
Bai PS; Hou P; Kong Y
Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA.
Liu C; Dai Q; Ding Q; Wei M; Kong X
Infect Agent Cancer; 2021 Mar; 16(1):18. PubMed ID: 33726794
[TBL] [Abstract][Full Text] [Related]
18. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
19. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
20. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
